A Study to Determine Safety & Efficacy of Autologous Human Platelet Lysate (HPL) in Facial Wrinkles(Nasolabial Folds)
A Prospective, Multicentric, Open Label, Bio-Interventional, Phase I/II Pilot Study To Evaluate The Safety And Efficacy Of Autologous Human Platelet Lysate (HPL) For Treatment of Facial Wrinkles (Nasolabial Folds)
1 other identifier
interventional
20
1 country
1
Brief Summary
This is a multicentre, open label, pilot study to evaluate safety and efficacy of Autologous Human Platelet Lysate (HPL) in subjects with Facial Wrinkles (Nasolabial Folds). The study is being conducted at 2 centers in India. The primary endpoints are Improvement in Wrinkle Severity Rating Scale ( WSRS ) as per ATLAS photographic grading at rest and on full smile and Global Aesthetic Improvement Scale (GAIS). The secondary endpoints are improvement in photographic assessment, Physician's assessment scores, Patient's assessment scores form enrollment to end of study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1
Started Apr 2012
Shorter than P25 for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2012
CompletedFirst Submitted
Initial submission to the registry
July 17, 2012
CompletedFirst Posted
Study publicly available on registry
July 19, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2012
CompletedJuly 25, 2012
July 1, 2012
6 months
July 17, 2012
July 24, 2012
Conditions
Outcome Measures
Primary Outcomes (1)
Wrinkle Severity Rating Scale as per ATLAS photographic grading at rest & on full smile
Day 0, End of Study - 3 months
Secondary Outcomes (1)
Global Aesthetic Improvement Scale
Day 0, End of study - Month 3
Other Outcomes (3)
Photographic assessments
Day 0, Month 1, Month 2, End of study - Month 3
Physician's assessment scores
End of Study - 3 months
Patient's assessment scores
End of Study - 3 months
Study Arms (1)
Study Group
OTHERAll subjects will receive a single injection of Autologous Human Platelet Lysate in the nasolabial region
Interventions
All subjects will receive a single injection of Autologous Human Platelet Lysate in the nasolabial region
Eligibility Criteria
You may qualify if:
- Subjects (male and female), aged 18 to 40 years (both inclusive).
- Subjects willing to refrain from any other treatment for Nasolabial Folds.
- Subjects who are willing to give informed consent and adhere to the study protocol.
You may not qualify if:
- Subjects receiving any aesthetic facial therapy 6 months prior to enrolment e.g. Botox, Fillers etc
- Subjects with history of Connective tissue disease
- Subjects with autoimmune diseases
- Subjects unwilling to or unable to comply with the study protocol.
- Subjects taking concomitant therapy that might interfere with the study results in the investigator's opinion or participating in another trial in the past 30days
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kasiak Research Pvt Ltd
Thane, Maharashtra, 400610, India
Study Officials
- PRINCIPAL INVESTIGATOR
Rachita Dhurat, Dr.
Dr Rachita's Skin, Trichology & Aesthetic Centre
- PRINCIPAL INVESTIGATOR
Geetanjali Shetty, Dr.
Kapadia Multispeciality Hospital
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 17, 2012
First Posted
July 19, 2012
Study Start
April 1, 2012
Primary Completion
October 1, 2012
Study Completion
November 1, 2012
Last Updated
July 25, 2012
Record last verified: 2012-07